AzTrials
AzTrials

Traumatic Rib FractureNCT01599403

Thoracic Blocks Versus Thoracic Epidural and Patient Controlled Anesthesia in Traumatic Rib Fracture Patients

A study testing Paravertebral Block, Intercostal Nerve Block and Epidural Block in people with Traumatic Rib Fracture, run by Brigham and Women's Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary objective of this study is to investigate whether continuous PVB is equal in efficacy to epidural anesthesia in terms of analgesia in patients with INR lower than 1.2, or is continuous ICNB equal in efficacy to PCA in terms of analgesia, if patients have INRs equal to or greater than 1.2. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Traumatic Rib Fracture
What is being tested?
Paravertebral Block, Intercostal Nerve Block and Epidural Block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteUnited States
Study dates
Apr 2012to 1 Feb 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects 18 years of age and greater
  • Inpatient on the BWH SICU, MICU, or hospital floor ward
  • Non-intubated at the time of block placement
  • Traumatic Rib Fractures three or greater
  • Block able to be placed within 12-24 hours of presentation to the emergency room
  • Ability to provide written informed consent.
  • Compliance with all ASRA and BWH Regional Anesthesia in Anticoagulated Patient guidelines for coagulation status.

Who cannot join

  • Subject is pregnant
  • Subject not expected to survive 48 hours due to traumatic injuries
  • Allergy to Ropivacaine or other local anesthetic
  • Any significant concomitant injuries potentially confounding data acquisition (e.g., traumatic brain injury, long bone fractures, intra-abdominal injuries)
  • Known allergy to lidocaine
  • Inability to provide written, informed consent
  • Known opioid medication dependence
  • Non-compliance with ARSA and BWH Regional Anesthesia in Anticoagulated Patient Guidelines.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115

Other trials in United States

About this study

Official title: Comparative Effectiveness of Continuous Thoracic Paravertebral Blocks Versus Thoracic Epidural and Continuous Intercostal Blocks Versus Patient-Controlled Anesthesia in Traumatic Rib Fracture Patients

The primary objective of this study is to investigate whether continuous PVB is equal in efficacy to epidural anesthesia in terms of analgesia in patients with INR lower than 1.2, or is continuous ICNB equal in efficacy to PCA in terms of analgesia, if patients have INRs equal to or greater than 1.2.

Read the detailed description

Rib fractures are the most common injury sustained following blunt trauma. Ziegler and Agarwal noted that in a population of more than 7000 trauma patients, 10% had fractured ribs. These injuries are normally the hallmark of significant chest trauma; and as the number of fractured ribs increases, there is an exponential increase in morbidity and mortality.

This injury therefore poses a challenging problem from both pulmonary and analgesia standpoints. Significant morbidity is often the result of hypoventilation leading to atelectasis, pneumonia, and respiratory failure. Pain management has been recognized as an important factor in preventing these complications.

Good analgesia may help to improve a patient's respiratory mechanics, leading to a decreased need for mechanical ventilatory support, a shortened hospital stay, and can dramatically alter the course of recovery impacting both morbidity and mortality.

For healthy patients with one to two fractured ribs, systemic analgesics may suffice. For more than three to four fractured ribs, studies and experience have reaffirmed the superior analgesia made possible with continuous thoracic epidural, continuous thoracic paravertebral, and continuous intercostal block, however, a comparative head to head trial comparing the relative merits and disadvantages of each technique has not been undertaken in multiple rib fracture patients. Placing a catheter, which is possible with the use of all three techniques, allows the continuation of analgesia for multiple days with just one block, which is an essential option when treating patients that are likely to need extended analgesia.

All options are not available for all patients, however, as the current American Society of Regional Anesthesiology advises against the performance of epidural or paravertebral blocks in patients with abnormal INR (at the BWH, equal or above 1.2, and/or treatment with other anticoagulants such gpIIb/IIIa inhibitors (heparin and heparin-like medications are usually acceptable within certain dosing time frames).

Rib fractures following trauma are associated with severe postoperative pain and significant morbidity. Atelectasis, pneumonia, pulmonary embolism (PE), and intensive care admission are related to poor analgesia and consequent immobility and splinting during inspiration. With traumatic multiple fractured ribs (MFR), concomitant lung injury is expected. The effect of this injury is exacerbated when the pain of MFR leads to guarding, shallow breaths, and suboptimal chest physiotherapy. Atelectasis, pneumonia, consolidation, and respiratory failure ensue, necessitating or prolonging assisted ventilation and/or oxygenation and increasing morbidity and mortality. Additionally, inadequately treated pain after rib fractures can lead to chronic pain and global deconditioning.

Without the implementation of effective regional and/or neuraxial analgesia, the need for the use of sedative and systemic opioid medications increases, which has the potential to increase the length of stay and increase complications such as delirium, aspiration, decreased mobility with subsequent greater deconditioning and increased risk for embolic events, addiction, and possibly chronic pain. These risks are even higher in older individuals (age > 55), in whom comorbidities and poor respiratory reserves conspire to increase morbidity and mortality, and who are less able to handle and recover from the side effects of sedative and systemic opioid medications. Additionally, trauma patients may also be at higher risk due to multiple, and often confounding, injuries.

Options for analgesia aside from regional blocks include the use of NSAIDs, acetaminophen, opioids, ketamine, and transdermal lidocaine (patch). The short-term disadvantages of NSAID include gastric irritation, platelet inhibition and renal injury. Acetaminophen at high doses is hepatotoxic. Powerful opioids are depressants, suppress cough, increase risk of delirium, and may promote respiratory complications even as they reduce pain. Ketamine causes dissociation and risk of hallucinations, often of an unpleasant nature. Assessment of head and abdominal injuries can be compromised by systemic opioids or ketamine. Of note, none of these medications at well tolerated doses are sufficient to greatly diminish the pain of MFR during chest physiotherapy and coughing, delaying recovery, and none of these treatments can, at well tolerated doses, provide sufficient analgesia without causing significant side effects, even in combination. Lidocaine patches over the fracture sites are ineffective.

Regional/neuraxial blocks provide superior analgesia, the impact of a successful block is immediate and substantial, and, especially regarding elderly, some authorities have categorically stated that most 55-65 year-olds with three or four fractured ribs should receive a regional block. The relative lack of systemic sedation makes it easier to monitor patients with head and abdominal injuries, and the reduced need for systemic medications obviates their inherent concomitant risks.

Though effective, the use of epidural blocks in the intubated and unresponsive patient, especially in the thoracic region, is currently not widely accepted for fear of inadvertent adverse neurologic complications. This said, the incidence of neurological complications associated with patients who cannot respond to incidental injury associated with the placement of epidural anesthesia under general anesthesia, as an example of an unresponsive patient, is not precisely known. Horlocker et al state the "possibility of serious complications may still be as high as 0.08%." Regardless of the exact incidence rate, the prevailing wisdom is that the risk benefit ratio does not support the practice of epidural/deep plexus regional anesthesia in unconscious patients because of the clear association of pain during placement or injection and subsequent injury, which speak to the need for feedback from the patient in preventing injury.

In comparison to epidural analgesia, the major complication of PVB and ICNB is that of pneumothorax with no documented accounts of nerve damage due to the lateral anatomic plane of medication delivery in reference to the central nerve axis. However, in patients with a chest tube this risk is effectively obviated. Moreover, the use of ultrasound, which greatly enhances the ability to avoid of the pleura, further improves the accuracy and safety of these blocks.

Additionally, in view of pain relief methods providing the greatest preservation of pulmonary spirometric function after thoracotomy-related rib trauma, the most effective analgesic method is paravertebral analgesia, with patients having approximately 75% of their preoperative values in the first 48 hours after surgery. Most other techniques e.g. traditional intercostal nerve blocks, epidural local anesthetics or local anesthetic-opiate combinations produce approximately a 55% preservation by 48 hours, with interpleural analgesia being the least effective, with a mean of 35% preservation by 48 hours, less even than TENS or cryoanalgesia. These findings suggest that a thoracic paravertebral block is the best available analgesic method in rib trauma patients: however, the above studies have been performed in the post-surgical setting and not the trauma setting, and concentrated their findings on respiratory parameters, and not pain relief, though the two may be related.

The primary question the investigators wish to answer in this study is whether continuous PVB is equal in efficacy to epidural anesthesia in terms of analgesia in patients with INR lower than 1.2, or is continuous ICNB equal in efficacy to PCA in terms of analgesia, if patients have INRs equal to or greater than 1.2 as measured by difference in visual analog pain scores after 48 hours. Secondary questions are: do PVBs and ICNBs result in a favorable side effect profile, lower complication rate, improved pulmonary mechanics, decreased need for intubation, decreased length of intubation, reduced supplemental oxygenation needs, reduced length of stay, improved speed to work with physical therapy and/or occupational therapy, lesser need for short/long term rehabilitation at discharge, and lesser development of chronic pain when compared to epidural block and opioid PCA in rib fracture patients.

Being tested
Paravertebral Block, Intercostal Nerve Block, Epidural Block
Keywords
Rib Fracture, Intercostal Nerve Block, Paravertebral Nerve Block
Medical subject headings
Rib Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Paravertebral BlockProcedure or surgery

    The paravertebral block consists of injection of local anesthetics into the area next to the spinal column and results in regional pain control. This technique of this block may be performed on multiple levels if there are extensive rib fractures and may be performed on both sides of the rib cage depending on injury.

  • Intercostal Nerve BlockProcedure or surgery

    The intercostal nerve block will consist of placing a catheter which delivers pain medication into the area between the ribs. This technique of this block may be performed on multiple levels if there are extensive rib fractures and may be performed on both sides of the rib cage depending on injury.

  • Epidural BlockProcedure or surgery

    The epidural block consists of continuous infusion of local anesthetics into the epidural catheter placed into the epidural space (next to the spinal column) and results in regional pain control. This technique of this block may be performed at the appropriate level so the pain of rib fracture may be better controlled.

Study groups in NCT01599403
Study groupRoleWhat they receive
Paravertebral BlockActive comparatorPatients will receive 1 or 2 paravertebral catheters for ongoing infusion of local anesthestic
Receives: Procedure: Paravertebral Block
Patient Controlled AnesthesiaNo interventionStandard usual care
Epidural BlockExperimentalIntervention: Patients will have epidural catheters placed for the infusion of local anesthetic solution to control pain (if qualified for this approach and randomized here)
Receives: Procedure: Epidural Block
Intercostal Nerve BlockActive comparatorPatients will receive intercostal catheters for the infusion of local anesthetic solution to control pain(if qualified for this arm and randomized here)
Receives: Procedure: Intercostal Nerve Block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary Outcome: Difference in Pain Scores at 48hrs

    The primary question investigators wish to answer in this study is whether continuous PVB is equal in efficacy to epidural anesthesia in terms of analgesia in patients with INR lower than 1.2, or is continuous ICNB equal in efficacy to PCA in terms of analgesia, if patients have INRs equal to or greater than 1.2 as measured by visual analog pain scales at 48 hours post treatment.

    Measured: 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2012 (estimated)
  2. Study startApr 2012
  3. Primary completion1 Feb 2017
  4. Study completion1 Feb 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01599403
Sponsor's protocol ID
2011P002702 Frendl
Status last verified
Feb 2017
First submitted
28 Feb 2012
Last updated
13 Feb 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Paravertebral Block, Intercostal Nerve Block and Epidural Block in people with Traumatic Rib Fracture, run by Brigham and Women's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary Outcome: Difference in Pain Scores at 48hrs (time frame: 2 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in